LGP — Little Green Pharma Income Statement
0.000.00%
Last trade - 00:00
- AU$39.01m
- AU$38.59m
- AU$19.86m
- 52
- 79
- 34
- 58
2019 June 30th | 2020 June 30th | R2021 June 30th | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 9 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.248 | 2.2 | 7 | 10.5 | 19.9 |
Cost of Revenue | |||||
Gross Profit | 0.048 | 1.12 | 4.24 | 3.38 | 10.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5.68 | 9.48 | -11.9 | 29.5 | 32.2 |
Operating Profit | -5.43 | -7.28 | 18.9 | -19 | -12.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.52 | -9.32 | 22.2 | -18.1 | -8.56 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.52 | -9.32 | 22.2 | -18.1 | -8.56 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -5.52 | -9.32 | 22.2 | -18.3 | -9.21 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.52 | -9.32 | 22.2 | -18.3 | -9.21 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.007 | -0.076 | -0.015 | -0.086 | -0.034 |
Dividends per Share |